Monday, October 03, 2016 7:32:53 PM
I have several doc friends, one in PA, one at Stanford in CA, and one in Vermont. The doc in PA is affiliated with a major health system (Pinnacle) in PA, the doc in Stanford is involved in research at Stanford University, and the doc in Vermont is on the Board at the University of Vermont Medical Center in Burlington. None of the three have heard diddly poopie squat about QUTR or any of it's products. That doesn't mean other docs haven't heard about it. But those three who are well-connected docs haven't. To me that says that there's not been enough promotion of the products OR it's all bogus.
You know when I'll get excited. I'll get excited when LF publishes in the American Journal of Medicine. In fact, if this thing he's got is so freaking great, why hasn't he published in the journal thus far? Seems to me that'd be a GREAT platform for him to generate interest. And he does have a gift for writing about this. So, I encourage him to do so. Or possibly he's smart enough to figure it'll never get published if it's not on the up and up. Something that all you who claim to be so high on this should consider.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM